Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis (AS).

biologic agents

  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 26 December 2014 - 08:35 AM

Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis (AS).

 

Golimumab, compared to placebo, may be the drug that provides the highest probability of achieving ASAS20 response in AS patients naive to biologic treatments at 12 weeks. PubMed, Clin Drug Investig, 2014 Nov 12. (Also see: Biologic Agents)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)